The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

Only a few patients have undergone an intensive gene therapy cure for sickle cell disease since it was approved by the FDA ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...

Hanx Biopharmaceuticals has dosed the first subject in a trial of HX044, a bispecific antibody designed for advanced solid tumours.

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...

Verastem's pipeline's emphasis is on RAS/MAPK-driven tumors, so the FDA's ruling might have a major influence on their ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug Administration (FDA) approving lenacapavir, a new prototype medication. It uses a ...

horse racing form guide explained Ascentage Pharma Announces Positive Data from Pivotal Registration Phase II Study of Oribatinib From DRG to DIP, where is the trigger point for refined management?

INR:3169. lottery sambad evening result National Medical Insurance Bureau: Establish a national consumables procurement system Innovative fluorescen ...